CS Duale demanded the swift removal of all substandard, falsified, poor-quality, counterfeit, and unregistered medicines from the Kenyan market.
The facility now stands as the first hospital in the country’s central zone to offer this advanced service to patients suffering from debilitating back conditions.
The approved funding will help countries build systems that keep communities safe, particularly in cross-border areas where health risks are highest.
The PEN-Plus strategy strengthens local hospitals to diagnose and manage complex illnesses requiring continuous care.
The new approach, published in Clinical Cancer Research, may equip clinicians with an additional tool to track tumor changes over time and modify treatment strategies accordingly.
The handover ceremony took place at the Kenya BioVax headquarters and was presided over by Dr. Charles Githinji, the Chairman of the Board of Directors.
The WHO’s African Regional Verification Commission for Measles and Rubella Elimination verified this achievement following its October 2025 meeting in Johannesburg, South Africa.
The agreement encompasses the manufacturing and supply of several Algorithm products licensed in the European Union and Japan.
Africa Genome Archiving for Response and Insight (AGARI) is a collaborative initiative developed in partnership with the African Society for Laboratory Medicine (ASLM) and African Union Member States.
This project marks the first hospital of its kind in the Gulf region, blending medical excellence with advanced urban planning.